Position in DNLI
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,212,741
+$1,942,828 QoQ
Shares Held
86,032
+512.0% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. DNLI ranks #82 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
336,990 | $167,393,033 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
230,151 | $143,508,345 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,694,250 | $94,996,587 | |
| 4 | INCY |
Incyte Corp
|
425,616 | $48,247,822 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
158,228 | $47,631,369 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
783,148 | $44,811,725 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
120,304 | $38,026,888 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
418,025 | $34,098,295 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,212,741 | 86,032 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $269,913 | 14,058 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $222,339 | 13,467 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $200,360 | 13,799 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $35,786 | 2,558 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $35,903 | 2,641 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $450,722 | 22,116 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $640,101 | 21,974 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $532,062 | 22,914 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $1,757,084 | 85,628 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $2,392,209 | 111,473 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $2,353,015 | 114,058 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,152,079 | 106,814 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,896,076 | 82,295 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $2,763,562 | 99,373 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $3,279,562 | 106,861 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $2,596,608 | 88,230 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,657,397 | 51,520 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $2,948,996 | 66,121 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $3,296,956 | 65,351 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $5,001,097 | 63,757 | Shares | Defined | 2021-08-04 | |
| 2021-03-31 | $2,738,857 | 47,966 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $6,708,756 | 80,095 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $1,956,281 | 54,599 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $1,320,203 | 54,599 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $1,255,974 | 71,729 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||